12.43 pm | 19 Dec 2007 |  Source: Moneycontrol.com

Ambareesh Baliga of Karvy Stock Broking is positive on Cipla, Ranbaxy and Dr Reddy's....

11.38 am | 14 Dec 2007 |  Source: Moneycontrol.com

Anil Manghnani of Modern Shares & Stock Brokers is of the view that there could be some more upside in Cipla, Dr Reddy's from current level. Probably ...

8.36 am | 06 Dec 2007 |  Source: Business Line

Sun Pharma’s generic drugs business in the US received a shot in the arm, after Novartis dropped a patent infringement suit against it and Watson Phar...

8.36 am | 05 Dec 2007 |  Source: Business Line

“Green” is the favourite colour of ABN Amro Bank for more reasons than one, reports Business Line. The environment-friendly bank, which has pioneered ...

3.16 pm | 04 Dec 2007 |  Source: CNBC-TV18

Saumen Chakraborty, CFO, Dr Reddy's Labs said that the Betapharm side of the business faced supply problems from Salutas and added that they have now ...

12.48 pm | 27 Nov 2007

SYGNIS AG & Dr. Reddy’s sign exclusive supply collaboration for Ax200 in stroke. The Agreement secures the supply of AX200 far beyond the clinical dev...

8.33 am | 27 Nov 2007 |  Source: Business Line

In the quest to develop drugs to treat certain chronic respiratory diseases, Dr Reddy’s Laboratories and Argenta Discovery Ltd, UK have announced mile...

4.42 pm | 26 Nov 2007

Argenta Discovery and Dr Reddy’s progress pre-clinical anti-inflammatory candidate to treat chronic respiratory disease...

11.31 am | 17 Nov 2007

Sorento Healthcare earns 6 nominations at the 2007 RX Club Awards. Sorento Healthcare is one of the leading healthcare agency in India started a decad...

8.30 am | 16 Nov 2007 |  Source: Business Line

Balaglitazone, a new diabetic drug candidate of Dr Reddy’s Laboratories, is currently undergoing phase III clinical trails and will hit the market by ...

2.22 pm | 06 Nov 2007 |  Source: Moneycontrol.com

CNBC-TV18 has learnt that Jubilant, Nicholas Piramal, Dr Reddy's and Dishman are in race to buy Pfizer's Irish unit....

4.37 pm | 31 Oct 2007 |  Source: Moneycontrol.com

If there is a big acquisition opportunity, Dr Reddy's promoters will be willing to dilute its equity stake to structure a deal. ...

6.27 pm | 24 Oct 2007

Dr. Reddy’s Q2 FY08 revenue at Rs 12,670 million; Net income at Rs 2,672 million...

4.52 pm | 24 Oct 2007 |  Source: Moneycontrol.com

Dr Reddy's Laboratories has announced its second quarter numbers. It has posted consolidated net profit of Rs 267.2 crore for the quarter ended Septem...

7.28 pm | 23 Oct 2007 |  Source: Moneycontrol.com

Dr Reddys Laboratories is to announce its second quarter results. According to CNBC-TV18 estimates, the company’s Q2FY08 net profit is seen down (US G...

8.43 am | 15 Oct 2007 |  Source: Business Line

The hived-off new drug research business of India’s top ten pharma companies could independently be worth $120 billion in market cap by 2015, acco...

8.40 am | 11 Oct 2007

The management of the Chennai-based Shasun Chemicals and Drugs Ltd is considering splitting the company into two entities — one for manufacturing and ...

8.49 am | 08 Oct 2007

The US Food and Drug Administration’s GIVE (Generic Initiative for Value and Efficiency) may pep up Indian generic drug makers eyeing the US market. M...

7.33 pm | 28 Sep 2007

It might get tougher to obtain the US patents but it is easier to challenge an existing product patent. That’s if a new set of US patent laws are appr...

1.39 pm | 19 Sep 2007

According to sources, Dr Reddy's has moved into binding bids for US based Bradley Pharma. Dr Reddy's has neither confirmed nor denied the news. ...